Search In this Thesis
   Search In this Thesis  
العنوان
MicroRNAs In Hepatocellular Carcinoma In chronic Hepatitis C Virus -Infected Egyptian Patients /
المؤلف
Ali, Ahmad Mahmoud Mohamed.
هيئة الاعداد
باحث / أحمد محمود محمد علي
مشرف / نجلاء على زايد
مشرف / مني ذكي شريف
مشرف / دينا إسماعيل عطيه
الموضوع
Carcinoma, Hepatocellular. Hepatitis C. MicroRNA.
تاريخ النشر
2014.
عدد الصفحات
104 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الطب
تاريخ الإجازة
30/12/2014
مكان الإجازة
جامعة بني سويف - كلية الطب - طب المناطق الحارة
الفهرس
Only 14 pages are availabe for public view

from 32

from 32

Abstract

The discovery of MicroRNAs circulating in the peripheral blood has opened new directions of research to identify new non-invasive ways of diagnosis of HCC. This study aims to evaluate seum level of MicroRNA885p5 as a biochemical marker for Hepatocellular carcinoma in chronic hepatitis C virus- infected Egyptian patients .
Patients were assigned into:
• group (A): 30patients with HCC who were diagnosed among patients of liver cirrhosis which HFLs detected on U/S examination, patients were diagnosed according to EASL guidelines(arterial hypervascularity and venous with late phase washout). (EASL 2012).
• group (B): This group included 15 patients with HCV related liver cirrhosis (Child A-C); diagnosed by clinical ,laboratory &sonographic evendence of liver cirrhosis.
• group (C): This group included 15 patients with chronic hepatitis C; who were diagnosed by seropositivity for HCV antibodies, HCV RNA by RT-PCR and histopathological evidence of chronic hepatitis .
Analysis of our results showed that seum level of MicroRNA885p5 was able to differentiate between cirrhotic & non-cirrhotic with 88.9 % sensitivity & 80 % specifcity these values were not encountered when levels were assesed between HCC &non-HCC with 36.7 %sensitivity & 80% specifcity.
80
Analysis of our results showed that there was a significant correlation between seum level MicroRNA885p5 & age of studied groups.
Different liver function tests & AFP were correlated with seum MicroRNA885p5, there was no significant correlation between seum MicroRNA885p5 & (AFP , ALT) while there was a good correlation between seum MicroRNA885p5 & synthetic liver functions (Albumin &INR).
Also analysis of our results showed that levels of AFP which were further classified into10-200 ng/dl(cutoff value should be set at 200ng/dL) &>200 ng/dl which it is considered to be gray zone for diagnosis of HCC , there was no significant difference between mean value of different levels of AFP & MicroRNA885-p5 in HCC group.
Disease severity was assessed by Child-Pugh classification & MELD score, there was no significant correlation between seum MicroRNA885p5 & MELD score among HCC&cirrhotic groups(n=45).
While There was a significant increase of seum MicroRNA885p5 with the increase of disease sverity assessed by Child-Pugh classification among HCC & cirrhotic groups.
Concerning to BCLC staging for HCC patients (73.3%)were stage A while stage B-D compromised( 26.7%), serum level of MicroRNA885p5 were significantly higher among HCC patients with stage B-D than those with stage A( p value = 0.046).
81
HFL(s) detected on U/S examination among patients with liver cirrhosis were further assessed by spiral CT abdomen,so there was no significant Correlation between seum level of MicroRNA885p5&(Number-Size) of HFL(s).
So MicroRNA885p5 could be considered a possible marker for significant liver damage rather than HCC marker.
The discovery of MicroRNAs circulating in the peripheral blood has opened new directions of research to identify new non-invasive ways of diagnosis of HCC. This study aims to evaluate seum level of MicroRNA885p5 as a biochemical marker for Hepatocellular carcinoma in chronic hepatitis C virus- infected Egyptian patients .
Patients were assigned into:
• group (A): 30patients with HCC who were diagnosed among patients of liver cirrhosis which HFLs detected on U/S examination, patients were diagnosed according to EASL guidelines(arterial hypervascularity and venous with late phase washout). (EASL 2012).
• group (B): This group included 15 patients with HCV related liver cirrhosis (Child A-C); diagnosed by clinical ,laboratory &sonographic evendence of liver cirrhosis.
• group (C): This group included 15 patients with chronic hepatitis C; who were diagnosed by seropositivity for HCV antibodies, HCV RNA by RT-PCR and histopathological evidence of chronic hepatitis .
Analysis of our results showed that seum level of MicroRNA885p5 was able to differentiate between cirrhotic & non-cirrhotic with 88.9 % sensitivity & 80 % specifcity these values were not encountered when levels were assesed between HCC &non-HCC with 36.7 %sensitivity & 80% specifcity.
80
Analysis of our results showed that there was a significant correlation between seum level MicroRNA885p5 & age of studied groups.
Different liver function tests & AFP were correlated with seum MicroRNA885p5, there was no significant correlation between seum MicroRNA885p5 & (AFP , ALT) while there was a good correlation between seum MicroRNA885p5 & synthetic liver functions (Albumin &INR).
Also analysis of our results showed that levels of AFP which were further classified into10-200 ng/dl(cutoff value should be set at 200ng/dL) &>200 ng/dl which it is considered to be gray zone for diagnosis of HCC , there was no significant difference between mean value of different levels of AFP & MicroRNA885-p5 in HCC group.
Disease severity was assessed by Child-Pugh classification & MELD score, there was no significant correlation between seum MicroRNA885p5 & MELD score among HCC&cirrhotic groups(n=45).
While There was a significant increase of seum MicroRNA885p5 with the increase of disease sverity assessed by Child-Pugh classification among HCC & cirrhotic groups.
Concerning to BCLC staging for HCC patients (73.3%)were stage A while stage B-D compromised( 26.7%), serum level of MicroRNA885p5 were significantly higher among HCC patients with stage B-D than those with stage A( p value = 0.046).
81
HFL(s) detected on U/S examination among patients with liver cirrhosis were further assessed by spiral CT abdomen,so there was no significant Correlation between seum level of MicroRNA885p5&(Number-Size) of HFL(s).
So MicroRNA885p5 could be considered a possible marker for significant liver damage rather than HCC marker.